Literature DB >> 27493130

Challenges in pediatric drug use: A pharmacist point of view.

S Balan1, M A Hassali2, V S L Mak3.   

Abstract

The pediatric population is an enormously diverse segment of population varying both in size and age. The diversity caused pharmacists face various challenges primarily related to procuring, provision as well as use of drugs in this group of patients. Pediatric dose calculation is particularly a concern for pharmacists. Another challenge faced by pharmacists is unavailability of suitable formulations for pediatric use. This has also led many pharmacists to prepare extemporaneous liquid preparations, even though stability data on such preparations are scarce. Some extemporaneous preparations contain excipients which are potentially harmful in children. Besides that, inadequate labeling and drug information for pediatric drug use had not only challenged pharmacists in recommending and optimizing drug use in children, but also inadvertently caused many drugs used outside the approved terms of the product license (off-label use). Pharmacists are striving to stay connected to overcome the common and comparable challenges faced in their day to day duties and strive to maximize the safe and effective use of medicines for children.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Challenges; Children; Pediatric; Pharmacists

Mesh:

Substances:

Year:  2016        PMID: 27493130     DOI: 10.1016/j.sapharm.2016.06.014

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  3 in total

Review 1.  A Scoping Review of Medications Studied in Pediatric Polypharmacy Research.

Authors:  Alexis E Horace; Negar Golchin; Elia M Pestana Knight; Neal V Dawson; Xuan Ma; James A Feinstein; Hannah K Johnson; Lawrence Kleinman; Paul M Bakaki
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

2.  A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia.

Authors:  Inese Sviestina; Dzintars Mozgis
Journal:  Eur J Hosp Pharm       Date:  2017-03-03

3.  Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.

Authors:  Hatim S AlKhatib; Sara Jalouqa; Nour Maraqa; Anna Ratka; Eman Elayeh; Suha Al Muhaissen
Journal:  BMC Health Serv Res       Date:  2019-11-08       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.